BioRestorative Therapies, Inc. Share Price Other OTC
Equities
BRTX
US0906554086
Biotechnology & Medical Research
Sales 2024 * | 60K 5.01M | Sales 2025 * | 60K 5.01M | Capitalization | 9.27M 774M |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.42B | Net income 2025 * | -20M -1.67B | EV / Sales 2024 * | 155 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 155 x |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.65
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/18/01 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04/21/04 |
Compliance Officer | 55 | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29/21/29 |
David Rosa
BRD | Director/Board Member | 59 | 29/21/29 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/11/13 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |